After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Gilead Sciences, Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – General industry. The current market capitalization of Gilead Sciences, Inc is $151.44B. A total of 8.14 million shares were traded on the day, compared to an average of 6.97M shares.
In the most recent transaction, O’Day Daniel Patrick sold 10,000 shares of GILD for 119.39 per share on Oct 28 ’25. After the transaction, the Chairman & CEO now owns 581,203 company shares. In a previous transaction on Oct 28 ’25, DANIEL ODAY bought 10,000 shares at 119.39 per share.
Among the insiders who sold shares, Dickinson Andrew D disposed of 2,500 shares on Oct 15 ’25 at a per-share price of $118.08. This resulted in the Chief Financial Officer holding 157,055 shares of GILD after the transaction. In another insider transaction, Mercier Johanna sold 3,000 shares at $118.08 per share on Oct 15 ’25. Company shares held by the Chief Commercial Officer now total 110,193.
Dividend
The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Gilead Sciences, Inc pays an annual dividend of $3.14, resulting in a dividend yield of 2.57%, and it has a price to earnings (P/E) ratio of 18.92.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, GILD has a high of $124.61 and a low of $86.08.
As of this writing, GILD has an earnings estimate of $1.93 per share for the current quarter. EPS was calculated based on a consensus of 19.0 estimates, with a high estimate of $2.2 per share and a lower estimate of $1.75. The company reported an EPS of $1.9 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. GILD’s latest balance sheet shows that the firm has $6.52B in Cash & Short Term Investments as of fiscal 2021. There were $26.70B in debt and $11.61B in liabilities at the time. Its Book Value Per Share was $17.28, while its Total Shareholder’s Equity was $21.06B.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GILD is Buy with a score of 4.38.
